Christine Vinci1. 1. Moffitt Cancer Center, Health Outcomes and Behavior, 4115 E Fowler Ave, Tampa, FL, 33617, USA. christine.vinci@moffitt.org.
Abstract
PURPOSE OF REVIEW: Cigarette smoking is the primary cause of cancer and is the leading preventable cause of morbidity and mortality. Cognitive behavioral therapy (CBT) is one of the most well-established and efficacious interventions for smoking cessation. The study of mindfulness-based interventions (MBIs) has increased exponentially in recent years, showing efficacy for smoking cessation as well. This review highlights research from the past 5 years examining CBT and MBIs for smoking cessation. RECENT FINDINGS: Both CBT and MBIs are efficacious for special populations (e.g., low SES; pregnant smokers) and have shown initial efficacy when delivered via mhealth/ehealth. CBT has shown efficacy when combined with another behavioral treatment (e.g., ACT). Continued research is needed on CBT and MBIs that have high potential for scalability. Understanding whether they are beneficial for certain populations (e.g., cancer survivors), along with determining for whom CBT vs MBIs are most effective, is also needed.
PURPOSE OF REVIEW: Cigarette smoking is the primary cause of cancer and is the leading preventable cause of morbidity and mortality. Cognitive behavioral therapy (CBT) is one of the most well-established and efficacious interventions for smoking cessation. The study of mindfulness-based interventions (MBIs) has increased exponentially in recent years, showing efficacy for smoking cessation as well. This review highlights research from the past 5 years examining CBT and MBIs for smoking cessation. RECENT FINDINGS: Both CBT and MBIs are efficacious for special populations (e.g., low SES; pregnant smokers) and have shown initial efficacy when delivered via mhealth/ehealth. CBT has shown efficacy when combined with another behavioral treatment (e.g., ACT). Continued research is needed on CBT and MBIs that have high potential for scalability. Understanding whether they are beneficial for certain populations (e.g., cancer survivors), along with determining for whom CBT vs MBIs are most effective, is also needed.
Authors: Monica Webb Hooper; David J Lee; Vani N Simmons; Karen O Brandon; Michael H Antoni; Marina Unrod; Taghrid Asfar; John B Correa; Tulay Koru-Sengul; Thomas H Brandon Journal: Contemp Clin Trials Date: 2018-04-01 Impact factor: 2.226
Authors: Damon J Vidrine; Summer G Frank-Pearce; Jennifer I Vidrine; Patricia D Tahay; Salma K Marani; Sixia Chen; Ying Yuan; Scott B Cantor; Alexander V Prokhorov Journal: JAMA Intern Med Date: 2019-02-01 Impact factor: 21.873
Authors: Karilynn M Rockhill; Van T Tong; Sherry L Farr; Cheryl L Robbins; Denise V D'Angelo; Lucinda J England Journal: J Womens Health (Larchmt) Date: 2015-12-30 Impact factor: 2.681
Authors: Jonathan B Bricker; Kristin E Mull; Julie A Kientz; Roger Vilardaga; Laina D Mercer; Katrina J Akioka; Jaimee L Heffner Journal: Drug Alcohol Depend Date: 2014-07-17 Impact factor: 4.492
Authors: Clara M Bradizza; Paul R Stasiewicz; Yue Zhuo; Melanie Ruszczyk; Stephen A Maisto; Joseph F Lucke; Thomas H Brandon; Rina D Eiden; Kim S Slosman; Paulette Giarratano Journal: Nicotine Tob Res Date: 2017-05-01 Impact factor: 4.244
Authors: Jessica L Burris; Tia N Borger; Timothy B Baker; Steven L Bernstein; Jamie S Ostroff; Nancy A Rigotti; Anne M Joseph Journal: J Gen Intern Med Date: 2022-04-26 Impact factor: 6.473